Drug Shortage Report for ERYTHRO-BASE

Last updated on 2022-04-02 History
Report ID 134555
Drug Identification Number 00682020
Brand name ERYTHRO-BASE
Common or Proper name Erythro-Base
Company Name AA PHARMA INC
Market Status DORMANT
Active Ingredient(s) ERYTHROMYCIN
Strength(s) 250MG
Dosage form(s) TABLET
Route of administration ORAL ORAL
Packaging size 100BTL
ATC code J01FA
ATC description MACROLIDES, LINCOSAMIDES AND STREPTOGRAMINS
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2021-02-22
Estimated end date 2022-09-01
Actual end date 2022-04-01
Shortage status Resolved
Updated date 2022-04-02
Company comments
Health Canada comments
Tier 3 Status No
Contact Address 1165 CREDITSTONE ROAD
VAUGHAN, ONTARIO
CANADA L4K 4N7
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v1 2021-02-22 English Compare
v2 2021-02-22 French Compare
v3 2021-02-23 English Compare
v4 2021-03-25 English Compare
v5 2021-03-25 French Compare
v6 2021-05-19 English Compare
v7 2021-05-19 French Compare
v8 2021-05-27 English Compare
v9 2021-05-27 French Compare
v10 2021-12-09 English Compare
v11 2021-12-09 French Compare
v12 2021-12-23 English Compare
v13 2021-12-23 French Compare
v14 2022-01-07 English Compare
v15 2022-01-07 French Compare
v16 2022-01-20 English Compare
v17 2022-01-20 French Compare
v18 2022-01-26 English Compare
v19 2022-01-26 French Compare
v20 2022-02-09 English Compare

Showing 1 to 20 of 28